110 PROMPT: phase II trial of maintenance pembrolizumab following weekly paclitaxel for recurrent ovarian, fallopian tube or peritoneal cancer

Tami Grunewald; Rowan Miller; Laura Tookman; Iain Mcneish; Rene Roux; Laura Farrelly; Amanda Feeney; Anne-Marie Hacker; Laura Hughes; Rupali Arora; Sergio Quezada; Nicholas Counsell; Jonathan Ledermann

doi:10.1136/ijgc-2024-ESGO.569

Article info

Poster and E-Posters

06. Ovarian cancer

110 PROMPT: phase II trial of maintenance pembrolizumab following weekly paclitaxel for recurrent ovarian, fallopian tube or peritoneal cancer

Authors

Tami Grunewald Imperial College Healthcare NHS Trust, London, UK PubMed articles Google scholar articles
Rowan Miller Barts Health NHS Trust, London, UK PubMed articles Google scholar articles
Laura Tookman Imperial College Healthcare NHS Trust, London, UK PubMed articles Google scholar articles
Iain Mcneish Department of Surgery and Cancer, Imperial College, London, UK PubMed articles Google scholar articles
Rene Roux Oxford University Hospitals NHS Foundation Trust, Oxford, UK PubMed articles Google scholar articles
Laura Farrelly Cancer Research UK and University College London Cancer Trials Centre, London, UK PubMed articles Google scholar articles
Amanda Feeney Cancer Research UK and University College London Cancer Trials Centre, London, UK PubMed articles Google scholar articles
Anne-Marie Hacker Cancer Research UK and University College London Cancer Trials Centre, London, UK PubMed articles Google scholar articles
Laura Hughes Cancer Research UK and University College London Cancer Trials Centre, London, UK PubMed articles Google scholar articles
Rupali Arora University College London Hospitals NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Sergio Quezada University College London Cancer Institute, London, UK PubMed articles Google scholar articles
Nicholas Counsell Cancer Research UK and University College London Cancer Trials Centre, London, UK PubMed articles Google scholar articles
Jonathan Ledermann University College London Cancer Institute, London, UK PubMed articles Google scholar articles

Citation

Grunewald T, Miller R, Tookman L, et al

110 PROMPT: phase II trial of maintenance pembrolizumab following weekly paclitaxel for recurrent ovarian, fallopian tube or peritoneal cancer

International Journal of Gynecologic Cancer 2024;34:A292.

Publication history

First published March 10, 2024.

Online issue publication

March 13, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password